Klaria Pharma Holding AB (OSTO:KLAR) Total Equity: kr-20.61 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:KLAR Klaria Pharma Holding AB OSTO:KLAR
9 GF Score
Price kr0.79
GF Value kr0.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Klaria Pharma Holding AB Total Equity?

Klaria Pharma Holding AB OSTO:KLAR +1.02% 9 Total Equity is kr-20.61 Mil as of Mar. 2026. GuruFocus rates OSTO:KLAR with a GF Score™ of 9/100 and a GF Value™ of kr0.32 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Klaria Pharma Holding AB's total equity for the quarter that ended in Mar. 2026 was kr-20.61 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Klaria Pharma Holding AB Total Equity Historical Data

* Premium members only.

The historical data trend for Klaria Pharma Holding AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Klaria Pharma Holding AB Total Equity Chart

Klaria Pharma Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.42 76.08 41.13 3.31 -12.04

Klaria Pharma Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.69 -18.39 4.55 -12.04 -20.61
OSTO:KLAR
9GF Score
Klaria Pharma Holding AB OSTO:KLAR
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Klaria Pharma Holding AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Klaria Pharma Holding AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=32.533-44.576
=-12.04

Klaria Pharma Holding AB's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=30.007-50.615
=-20.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr-20.61 Mil mean?
Klaria Pharma Holding AB (OSTO:KLAR) has a Total Equity of kr-20.61 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Klaria Pharma Holding AB and its competitors.
Is Klaria Pharma Holding AB's Total Equity too high?
Klaria Pharma Holding AB's current Total Equity is kr-20.61 Mil. Overall, Klaria Pharma Holding AB has a GF Score™ of 9/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Klaria Pharma Holding AB's Total Equity compare to ZTS and UTHR?
Klaria Pharma Holding AB's Total Equity of kr-20.61 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Klaria Pharma Holding AB and its competitors. Klaria Pharma Holding AB's current Total Equity is kr-20.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klaria Pharma Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Klaria Pharma Holding AB (OSTO:KLAR) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.32, compared to a current price of kr0.79 — trading 146.6% above its estimated fair value. The current Total Equity is kr-20.61 Mil. Klaria Pharma Holding AB's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Klaria Pharma Holding AB (OSTO:KLAR), the current Total Equity is kr-20.61 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Klaria Pharma Holding AB (OSTO:KLAR) Overvalued in 2026?

Based on GuruFocus' analysis, Klaria Pharma Holding AB stock appears to be overvalued. The current stock price of kr0.79 is trading 146.6% above its estimated GF Value™ of kr0.32. GuruFocus considers Klaria Pharma Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:KLAR:

  • Total Equity: kr-20.61 Mil
  • GF Value™: kr0.32 vs. price of kr0.79 (146.6% above fair value)
  • GF Score™: 9/100 with 6 warning signs

No single metric tells the full story. See the OSTO:KLAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Klaria Pharma Holding AB Business Description

Other Exchanges 6FN:Germany
Address Virdings Alle 2, Uppsala, CHE, 754 50
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
9GF Score

Get the complete analysis for OSTO:KLAR

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.79
Price
kr0.32
GF Value